Method of treating diseased, injured or abnormal cartilage with hyaluronic acid and growth factors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 11, 2003
Issued Date -
N/A
app pub date -
Apr 22, 1999
filing date -
Mar 5, 1996
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A composition is provided for treating diseased, injured or diseased cartilage comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at the site for a period of time sufficient to alleviate the symptoms of the disease, injury or abnormality. Preferably hyaluronic acid is used in a composition range of 0.01-4% by weight and the preferred growth factor is IGF-I, present in a concentration range of about 10.sup.-6 to 100 mg/ml.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully